BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 24305625)

  • 1. Providing Safe and Effective Preventative Antiretroviral Prophylaxis to HIV-exposed Newborns via a Novel Drug Delivery System in Tanzania.
    Dahinten AP; Dow DE; Cunningham CK; Msuya LJ; Mmbaga BT; Malkin RA
    Pediatr Infect Dis J; 2016 Sep; 35(9):987-91. PubMed ID: 27195602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Value of Emerging Bioanalytical Methods for Drug Measurements: A Scoping Review of Their Applicability for Medication Adherence and Therapeutic Drug Monitoring.
    Zijp TR; Izzah Z; Åberg C; Gan CT; Bakker SJL; Touw DJ; van Boven JFM
    Drugs; 2021 Nov; 81(17):1983-2002. PubMed ID: 34724175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence-enhancing interventions for active antiretroviral therapy in sub-Saharan Africa: a systematic review and meta-analysis.
    Mathes T; Antoine SL; Pieper D
    Sex Health; 2014 Jul; 11(3):230-9. PubMed ID: 24966025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring patient engagement with HIV care in sub-Saharan Africa: a scoping study.
    Keene CM; Ragunathan A; Euvrard J; English M; McKnight J; Orrell C;
    J Int AIDS Soc; 2022 Oct; 25(10):e26025. PubMed ID: 36285618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers and biometric measures of adherence to use of ARV-based vaginal rings.
    Stalter RM; Moench TR; MacQueen KM; Tolley EE; Owen DH;
    J Int AIDS Soc; 2016; 19(1):20746. PubMed ID: 27142091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saliva as a specimen for therapeutic drug monitoring in pharmacies.
    Zuidema J; Höld KM; de Boer D; Maes RA
    Pharm World Sci; 1996 Dec; 18(6):193-4. PubMed ID: 9010881
    [No Abstract]   [Full Text] [Related]  

  • 7. Nevirapine concentration in nonstimulated saliva: an alternative to plasma sampling in children with human immunodeficiency virus infection.
    Rakhmanina NY; Capparelli EV; van den Anker JN; Williams K; Sever JL; Spiegel HM; Soldin SJ
    Ther Drug Monit; 2007 Feb; 29(1):110-7. PubMed ID: 17304158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of saliva as an alternative matrix for monitoring plasma Zidovudine, Lamivudine and nevirapine concentrations in Rwanda.
    Gras A; Schneider S; Karasi JC; Ternes AM; Sauvageot N; Karasi-Omes C; Henry AP; Schmit JC; Seguin-Devaux C; Arendt V
    Curr HIV Res; 2011 Jun; 9(4):223-8. PubMed ID: 21671885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring of nevirapine in resource-limited settings.
    L'homme RF; Muro EP; Droste JA; Wolters LR; van Ewijk-Beneken Kolmer NW; Schimana W; Burger DM
    Clin Infect Dis; 2008 Nov; 47(10):1339-44. PubMed ID: 18922070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of nevirapine in saliva in Uganda using high performance liquid chromatography and a low cost thin-layer chromatography technique.
    Lamorde M; Fillekes Q; Sigaloff K; Kityo C; Buzibye A; Kayiwa J; Merry C; Nakatudde-Katumba L; Burger D; de Wit TF
    BMC Infect Dis; 2014 Sep; 14():473. PubMed ID: 25176164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients.
    Baxi SM; Greenblatt RM; Bacchetti P; Jin C; French AL; Keller MJ; Augenbraun MH; Gange SJ; Liu C; Mack WJ; Gandhi M;
    PLoS One; 2015; 10(6):e0129100. PubMed ID: 26053176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nevirapine concentrations in saliva measured by thin layer chromatography and self-reported adherence in patients on antiretroviral therapy at Kilimanjaro Christian Medical Centre, Tanzania.
    George L; Muro EP; Ndaro A; Dolmans W; Burger DM; Kisanga ER
    Ther Drug Monit; 2014 Jun; 36(3):366-70. PubMed ID: 24305625
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.